Advanced Oncotherapy

Advanced Oncotherapy is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. Our aim is to create a bright future in cancer care with our advanced LIGHT technology. Vision: To develop a more affordable proton-based radiotherapy system, using an innovative and clinically more effective technology, and saving more cancer lives. Mission: To facilitate the wider use of radiation with protons for treating all forms of radio-sensitive cancers by commercialising a novel technology, and building on the success and scientific know-how of CERN (Centre Européen pour la Recherche Nucléaire).
Type
Public
HQ
London, GB
Founded
1994
Size (employees)
51 (est)
Advanced Oncotherapy was founded in 1994 and is headquartered in London, GB

Advanced Oncotherapy Office Locations

Advanced Oncotherapy has offices in London, Syracuse and Rolle
London, GB (HQ)
4-7 Manchester St
Rolle, CH
23 Route de Genève
Syracuse, US
1009 E Fayette St

Advanced Oncotherapy Financials and Metrics

Advanced Oncotherapy Financials

Advanced Oncotherapy's revenue was reported to be £84.2 k in FY, 2015 which is a 21% decrease from the previous period.
GBP

Net income (FY, 2016)

(10.4 m)

EBITDA (FY, 2016)

(12.7 m)

EBIT (FY, 2016)

(13.1 m)

Market capitalization (20-Oct-2017)

22.8 m

Closing share price (20-Oct-2017)

0.3

Cash (31-Dec-2016)

1.4 m

EV

21.9 m
Advanced Oncotherapy's current market capitalization is £22.8 m.
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.1 m2.9 m3.4 m1.4 m71 k100 k68.9 k106.4 k84.2 k

Revenue growth, %

54%(21%)

Cost of goods sold

163 k416 k455.3 k1.2 m713156 k202.7 k

Gross profit

2 m2.4 m3 m200 k99.3 k(87 k)(96.3 k)
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

119 k2.5 m268.6 k148.4 k24.2 k57.8 k148.8 k1.5 m9 m1.4 m

Accounts Receivable

152 k128.6 k173.4 k2.1 m1.1 m2.9 k28.6 k73.6 k

Inventories

37.2 k1.1 m4.4 m7.4 m

Current Assets

665 k3 m781.1 k2.7 m1.5 m1.5 m1.4 m3.2 m16.7 m12.5 m
    Y, 2016

    EV/EBITDA

    -1.7 x

    EV/EBIT

    -1.7 x

    EV/CFO

    -2 x

    Financial Leverage

    1.1 x
    Show all financial metrics

    Advanced Oncotherapy Market Value History

    Traffic Overview of Advanced Oncotherapy

    Advanced Oncotherapy Online and Social Media Presence

    Advanced Oncotherapy Company Life and Culture

    You may also be interested in